Skip to content
Search

Latest Stories

2 Sisters Food Group to sell its Christmas pudding-maker

THE 2 Sister's Food Group (2SFG), run by multi-millionaire businessman Ranjit Singh Boparan is reportedly seeking a buyer for its Christmas pudding-making facility.

The business is apparently auctioning Matthew Walker, a pudding manufacturer which supplies retailers such as Aldi and Asda, as it struggles to contend with a series of debts.


According to reports, advisory firm Stamford Partners has been appointed by 2SFG to handle the sale process, which is expected to reach £80 million.

The 2SFG website states the business directly employs about 120 people. The group has struggled in recent times as it decreased its operations in the wake of a food standards scandal in 2017.

An investigative report by ITV and The Guardian uncovered a number of breaches in food hygiene standards at the company's West Bromwich poultry processing site, leading to the suspension of production at the facility for five weeks.

The company sold pizza brand Goodfella's for around £200m and its red meat operations to an Irish manufacturer for an undisclosed sum last year.

In December 2018, the group also sold off a child sandwiches, wraps, and rolls unit to Samworth Brothers.

2SFG, which was founded in 1993, supplies poultry products to some of the country's major supermarket chains, including Marks & Spencer, Tesco, Sainsbury's, Aldi, and WI.

Boparan, known as the 'the chicken king' stepped down as CEO of 2SFG, after 25 years.

This year's Eastern Eye Asian Rich List-published by the Asian Media Group valued Boparan at £585m.

More For You

pharmaceuticals

UK becomes the only country in the world to have secured a zero per cent tariff rate for pharmaceutical shipments

iStock

UK secures zero-tariff deal with US on pharmaceuticals

Highlights

  • UK pharmaceutical exports worth £5bn annually protected from US tariffs for three years.
  • NHS spending on medicines to double from 0.3 per cent to 0.6 per cent of GDP over next decade.
  • Deal safeguards jobs at major British drugmakers including GSK and AstraZeneca.
The UK has secured a landmark deal with the United States guaranteeing zero tariffs on pharmaceutical exports. The UK government said it was the only country in the world to have secured a zero per cent tariff rate for pharmaceutical shipments.

Under the agreement announced on Monday, the NHS will pay more for medicines in return for a three-year guarantee that US import taxes on pharmaceuticals made in Britain will remain at zero per cent.

The deal comes after US President Donald Trump threatened to raise tariffs to as high as 100 per cent on branded drug imports, raising alarm for major British drugmakers including GSK and AstraZeneca.

Keep ReadingShow less